Status:
COMPLETED
Diabetes Management Intervention For South Asians
Lead Sponsor:
NYU Langone Health
Collaborating Sponsors:
National Institute on Minority Health and Health Disparities (NIMHD)
Conditions:
HbA1c
Diabetes
Eligibility:
All Genders
21-75 years
Phase:
NA
Brief Summary
The goal of this study is to evaluate the effectiveness and implementation process of a multi-level, integrated intervention to decrease HbA1c among South Asians with uncontrolled diabetes, including ...
Eligibility Criteria
Inclusion
- South Asian ethnicity (identified through a race and language code available in the EHR);
- an appointment with a physician for routine non-emergent primary care in the last 12 months
- diagnosis of diabetes
- an HbA1c reading of \>7 in the last 12 months
Exclusion
- Pregnant women and visits to obstetrician/gynecologist are excluded from the study
Key Trial Info
Start Date :
July 11 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2024
Estimated Enrollment :
859 Patients enrolled
Trial Details
Trial ID
NCT03333044
Start Date
July 11 2019
End Date
June 30 2024
Last Update
September 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
One Park Avenue
New York, New York, United States, 10016